Characteristics |
Corresponding value |
Age(years) |
|
Mean±SDMedian |
42.7±1.4 |
Distributionn(%) |
45 |
10-19 |
27 (7.4%) |
20-29 |
53 (14.4%) |
30-39 |
68 (18.5%) |
40-49 |
66 (18%) |
50-59 |
111 (30.2%) |
60-69 |
37 (10.1%) |
70-79 |
5 (1.4%) |
Sex |
|
Female(n[%]) |
186 (50.7%) |
Male (n[%]) |
181 (49.3%) |
Cancer Type (n [%]) |
|
Gastro-intestinal |
108 (29.4%) |
Head and Neck |
69 (18.8%) |
Genitourinary |
60 (16.3%) |
Sarcoma |
46 (12.5%) |
Others |
84 (22.9%) |
Metastasis stage determined (n [%]) |
184 (50.1%) |
Metastasis stage IV cancer (n [%]) |
68 (18.5%) |
Co-morbidity exist (n [%] |
80 (21.8%) |
Number of medications |
|
Mean + SD |
6.4 + 0.97 |
Median |
6.0 |
Minimum |
4 |
Maximum |
10 |
Length of Hospital stay (days) |
|
Mean + SD |
2.6+2.4 |
Median |
2 |
1-2 days (n [%]) |
209 (56.9%) |
3-5 days (n [%]) |
150 (40.9%) |
6 days (n [%]) |
8 (2.2%) |
|